Hepatitis C Infection Among Pregnant Women in British Columbia: Reported Prevalence and Critical Appraisal of Current Prenatal Screening Methods
Deborah Money(University of British Columbia), Valencia P. Remple(BC Centre for Disease Control), Patrick Doyle(University of British Columbia), Eric M. Yoshida(Vancouver General Hospital), Mel Krajden(University of British Columbia), Simon Dobson(Baylor College of Medicine), Emily Wagner(University of British Columbia), Audrey Blasig(University of British Columbia), David Pi(University of British Columbia), David M. Patrick(BC Centre for Disease Control), Mark Bigham(Canadian Blood Services), Kevin J.P. Craib(University of British Columbia)
Cited by 21
Related Papers
Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options
|New England Journal of Medicine|2013|1.1k
ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis
|New England Journal of Medicine|2014|877
A Perfect Storm: Impact of Genomic Variation and Serial Vaccination on Low Influenza Vaccine Effectiveness During the 2014–2015 Season
|Clinical Infectious Diseases|2016|232
Serial Vaccination and the Antigenic Distance Hypothesis: Effects on Influenza Vaccine Effectiveness During A(H3N2) Epidemics in Canada, 2010–2011 to 2014–2015
|The Journal of Infectious Diseases|2017|170